INHIBITION OF NF-KAPPA-B-DEPENDENT TRANSCRIPTION OF HUMAN-IMMUNODEFICIENCY-VIRUS-1 PROMOTER BY A PHOSPHODIESTER COMPOUND OF VITAMIN-C AND VITAMIN-E, EPC-K1
F. Hirano et al., INHIBITION OF NF-KAPPA-B-DEPENDENT TRANSCRIPTION OF HUMAN-IMMUNODEFICIENCY-VIRUS-1 PROMOTER BY A PHOSPHODIESTER COMPOUND OF VITAMIN-C AND VITAMIN-E, EPC-K1, Immunopharmacology, 39(1), 1998, pp. 31-38
We investigated the effect of EPC-K1, which is a phosphodiester compou
nd of vitamin E and vitamin C, on NF-kappa B activity in human culture
d astrocytoma cells T98G. In TNF alpha-stimulated T98G cells, treatmen
t with EPC-K1 inhibited both DNA binding activity and transactivation
of NF-kappa B in a dose-dependent manner, and the suppressive effect o
f EPC-K1 was stronger than either that of vitamin E or vitamin C. More
over, we showed that in TNF alpha-stimulated T98G cells treatment with
EPC-K1 repressed NF-kappa B-dependent activation of the human immunod
eficiency virus 1 promoter. In contrast, TNF alpha-induced activation
of the human immunodeficiency virus 1 promoter was not completely inhi
bited by either treatment with vitamin E or vitamin C. We, thus, sugge
st that EPC-K1 is considered to be one of the inhibitory agents of NF-
kappa B. (C) 1998 Elsevier Science B.V.